What opportunity was missed at the press event yesterday? Perhaps the chance to get a little short-term sizzle and beef up the trading volume for a day or two? Which is to say, the chance for DMRJ to unload a bunch more shares. Personally, one of the lessons I took from last week was that IMSC won’t trade higher than $1.50 until DMRJ’s debt is repaid via a refinancing or DMRJ simply runs out of shares to convert.
I wouldn’t cast Mr. Bolduc in a B-220 informercial, but he’s a numbers guy who has been around the block and was able to keep this company funded under circumstances where the continued viability of the enterprise was doubtful. With the DMRJ facility set to expire in March, I would rather have a numbers guy at the tiller than a rah-rah cheerleader
I believe in time the sales and financial results will speak for themselves. I hope Mr. Bolduc dedicates his time to putting stockholders in the best possible position to capitalize on those results when they come. That means (a) cleaning up the financial situation and providing clarity as to the fully diluted ownership structure of Implant, and (b) getting rid of the “going concern” qualification in their financial statements. You can forget any institutional interest in Implant, whether or not we are listed on a national exchange, until those events occur.
My only quibble with the Friday call was his characterization of DMRJ as an “investor.” They’re not, and I hope he understands that and does not suffer from some misguided sense of loyalty because “they were there when no one else was.” They’ve taken risk, and they’ve been rewarded for that already. He’s under no moral obligation to “stick with them.” Its just business…if the roles were reversed, they’d do it to Implant in a heartbeat.
AI
